The insider trading case against French doctor Yves Benhamou is growing increasingly torrid.
First we learn his tips are alleged to have helped a hedge fund avoid millions of dollars worth of losses.
Then we learn that the associated hedge fund is probably FrontPoint.
Then we learn that there is a connection between this insider trading scam to another scam involving SAC Capital.
In light of all the drama, we were inspired to take a look at the biggest insider trading scandals to rock the finance world over the past few decades. We included only people who were charged with insider trading. Let us know who else shocked you.
The scandal involving i-banker Dennis Levine of Drexel Burnham Lambert (DBL) and arbitrage king Ivan Boesky, brought down several Wall Street titans and DBL - arguably the 'richest and most feared firm on Wall Street.' Boesky earned $50 million in profits from the tips; Levine's 'biggest insider trade' earned him a profit of $2.69 million. It was because 'Boesky hit home runs on nearly every major deal in the 1980s - Getty Oil, Nabisco, Gulf Oil, Chevron, Texaco' that the SEC realised something was up.
Source: New York Magazine
In 2001, America's sweetheart, Martha Stewart, sold $228,000 worth of ImClone biotech stock the day after her friend and founder of ImClone, Sam Waksal, sold his shares and told his family to sell out too based on insider information. In '04, Stewart was found guilty of conspiracy, obstruction of an agency proceeding, and making false statements to federal investigators. She went to prison for five months.
Source: New York Magazine
Former Pequot Capital CEO Art Samberg blatantly asked Microsoft employee David Zilkha for insider information about the tech company in several emails during 2001, which then helped net his hedge fund $2.1 million. Samberg settled and paid the SEC $28 million. Pequot, once one of the most famous hedge funds on the Street, was forced to close its doors by mid-2009.
Australia's most famous banker, Rene Rivikin, was convicted of using confidential, market-sensitive information to earn just $346 on 50,000 Qantas shares he bought in '01 within hours of learning Qantas would merge with Impulse airlines. Rivkin was found guilty in '04, banned from stockbroking for life, sentenced to 9 months jail, all for less than a $400 bonus. He committed suicide in '05.
Source: The Sydney Morning Herald
Yoshiaki Murakami's hedge fund bought 1.93 million shares in Nippon Broadcasting after he was told that internet and financial services company, Livedoor, was attempting to gain a 5% stake in the broadcaster. Murakami was arrested in '06 for acting on non-public information that earned him $25.5 million. The wider Livedoor scandal rocked the Japanese economy; the Nikkei tumbled, the stockmarket lost 6% over 2 days, with Livedoor's value plummeting 52% over 5 days.
A $15 million scam and the biggest insider trading scandal since Boesky-gate, was allegedly hatched at the Grand Central Oyster Bar. Mitchel Guttenberg, an executive director at UBS, tipped off hedge funds and traders about forthcoming analyst upgrades and downgrades on stocks including Allstate and CVS. David Tavdy and Erik Franklin paid hundreds of thousands of dollars for the tips, earning $4 million from the resulting trades.
Source: New York Post
Randi Collotta, a former compliance officer for Morgan Stanley, divulged non-public information about four M&A deals to her husband and a Floridian trader, who then passed the information to portfolio managers at a Bear Stearns hedge fund (who incidentally, were also trading illegally on Guttenberg tips). The Collotta's earned $9,000 for their tips, which helped make others $600,000.
Billionaire hedge-fund manager and founder of the Galleon Group, Raj Rajaratnam, as well as 19 others used secret information about public companies to make investments that earned them $60 million in profits. The giant scam involved IBM, McKinsey, Bear Stearns, Goldman Sachs, Google, Berkshire Hathaway and a bunch of traders, lawyers and executives.
Alleged insider trading by a Dr. Yves Benhamou may have allowed FrontPoint's healthcare funds - overseen by Chip Skowron - to avoid $30 M in losses. Benhamou is accused of tipping off FrontPoint when trials for a potential hepatitis drug were unsuccessful (Benhamou worked for HGSI, which makes the drug). The funds then sold 6 million HGSI shares on key dates before negative trial results were announced.
NOW WATCH: Money & Markets videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.